New Jersey A427 requires the Cannabis Regulatory Commission to monitor and cap prices for medical cannabis.
New Jersey A427 mandates the Cannabis Regulatory Commission to oversee and regulate prices for medical cannabis. The commission is tasked with monitoring prices of all medical cannabis, products, and related supplies sold or dispensed by cultivators, manufacturers, dispensaries, and clinical registrants. If deemed necessary, the commission can establish a six-month price cap on these entities to ensure prices are reasonable and consistent with actual costs. The bill also outlines procedures for permit applications, background checks, and penalties for non-compliance.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.